Skip to content
StockMarketAgent
Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

EBR/NYXH stock hub

EBR/NYXH has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

EBR/NYXHis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
119.2M
Euronext Brussels
Market data

Price

Recent price action with selectable time range.

EBR/NYXHEBR/NYXH
—
Loading chart…
In the news

Latest news · EBR/NYXH

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-111
P25 n/aP50 n/aP75 n/a
ROIC-45.9
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All EBR/NYXH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
174
Groups with data
11
Currency
EUR
Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Belgium
Country code
BE
Employees
153.7
Employees Change
-29.9%
Employees Change Percent
-16.29
Enterprise value
EUR 113.3M
Exchange
Euronext Brussels
Financial currency
EUR
First seen
2026-05-10
Industry
Medical Instruments & Supplies
Isin
BE0974358906
Last refreshed
2026-05-10
Market cap
EUR 119.2M
Price
EUR 2.73
Price currency
EUR
Rev Per Employee
65,064.94x
Sector
Healthcare
Sic
3841
Symbol
ebr/NYXH
Website
https://www.nyxoah.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-75.58%
EV Earnings
-1.26x
EV/FCF
-1.62x
EV/Sales
11.3x
FCF yield
-58.54%
P/B ratio
2.43x
P/S ratio
11.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

15
MetricValue
Gross margin
63.13%
Gross Profit
EUR 6.3M
Gross Profit Growth
113.07%
Gross Profit Growth Q
290.63%
Gross Profit Growth3 Y
48.44%
Gross Profit Growth5 Y
176.7%
Net Income
EUR -90.1M
Pretax Margin
-888.98%
Profit Per Employee
EUR -584,968
ROA
-37.67
Roa5y
-21.78
ROCE
-120
ROE
-111
Roe5y
-50.46
ROIC
-45.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

7
MetricValue
Cagr1y
-51.19%
Cagr3y
-28.47%
Cagr5y
-32.49%
Revenue Growth
121.63x
Revenue Growth Q
346.87x
Revenue Growth3 Y
48.11x
Revenue Growth5 Y
170.65x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
EUR 0.07
Assets
EUR 118.5M
Cash
EUR 48M
Current Assets
EUR 61.2M
Current Liabilities
EUR 49M
Debt
EUR 42.1M
Debt Equity
EUR 0.86
Debt FCF
EUR -0.6
Equity
EUR 49.1M
Interest Coverage
-46.43
Liabilities
EUR 69.3M
Long Term Assets
EUR 57.3M
Long Term Liabilities
EUR 20.4M
Net Cash
EUR 5.9M
Net Cash By Market Cap
EUR 4.97
Net Cash Growth
-90.58%
Net Debt Equity
EUR -0.12
Tangible Book Value
EUR 48.7M
Tangible Book Value Per Share
EUR 1.13
WACC
7.58

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.25
Inventory Turnover
0.79
Net Working Capital
EUR -12M
Quick ratio
1.14
Working Capital
EUR 12.3M
Working Capital Turnover
EUR 0.23

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-16.38%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
-51.16%
200-day SMA
4.2
3Y total return
-63.4%
50-day SMA
2.82
50-day SMA vs 200-day SMA
50under200
5Y total return
-85.97%
All Time High
30
All Time High Change
-90.9%
All Time High Date
2021-07-13
All Time Low
2.35
All Time Low Change
16.17%
All Time Low Date
2026-04-13
ATR
0.16
Beta
0.88
Beta1y
0.66
Beta2y
1.06
Ch YTD
-33.17
High
2.8
High52
8.87
High52 Date
2025-08-11
High52ch
-69.22%
Low
2.69
Low52
2.35
Low52 Date
2026-04-13
Low52ch
16.17%
Ma50ch
-3.29%
Price vs 200-day SMA
-34.94%
RSI
51.26
RSI Monthly
35.79
RSI Weekly
34.1
Sharpe ratio
-0.72x
Sortino ratio
-0.96
Total Return
-16.38%
Tr YTD
-33.17
Tr1m
-3.87%
Tr1w
6.23%
Tr3m
-30.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR -83.4M
Operating margin
-832.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
24,490,502%
Net Borrowing
21,188,000
Shares Insiders
18.53%
Shares Institutions
13.79%
Shares Out
43,662,403
Shares Qo Q
7.16%
Shares Yo Y
16.38%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

52
MetricValue
Adjusted FCF
EUR -74.7M
Average Volume
63,321.5x
Bv Per Share
1.14
CAPEX
EUR -805,000
Ch1m
-3.87
Ch1w
6.23
Ch1y
-51.16
Ch3m
-30.71
Ch3y
-63.4
Ch5y
-85.97
Ch6m
-35.76
Change
-0.36%
Change From Open
0.37
Close
2.74
Days Gap
-0.73
Depreciation Amortization
1,088,000
Dollar Volume
96,254.3
Earnings Date
2026-05-12
EBIT
EUR -83.4M
EBITDA
EUR -82.4M
EPS
EUR -2.36
F Score
3
FCF
EUR -69.8M
FCF EV Yield
-61.61x
FCF Per Share
EUR -1.6
Financing CF
38,107,000
Fiscal Year End
December
Founded
2,009
Income Tax
EUR 1M
Investing CF
28,332,000
Is Primary Listing
1
Last Earnings Date
2026-03-19
Last Report Date
2025-12-31
Ma150
3.84
Ma150ch
-28.81%
Ma20
2.66
Ma20ch
2.75%
Net CF
-4,185,000
Next Earnings Date
2026-05-12
Open
2.72
Position In Range
39.13
Ppne
5,345,000
Price Date
2026-05-08
Ptbv Ratio
2.45
Relative Volume
0.56x
Revenue
10,020,000x
SBC By Revenue
48.76x
Share Based Comp
4,886,000
Tax By Revenue
10.07x
Tr6m
-35.76%
Volume
35,258
Z Score
-3.6
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does EBR/NYXH pay a dividend?

Capital-return profile for this ticker.

Performance

EBR/NYXH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-51.2%
S&P 500 1Y: n/a
3Y total return
-63.4%
S&P 500 3Y: n/a
5Y total return
-86.0%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns EBR/NYXH?

Insider, institutional, and short-interest positioning.

Institutional ownership
+13.8%
Share of float held by funds and institutions
Insider ownership
+18.5%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+16.4%
Negative means the company is buying back shares.
Technical

EBR/NYXH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
51.3
Neutral momentum band
Price vs 200-day MA
-34.9%
50/200-day relationship not available
Beta (5Y)
0.88
Moves roughly with the market
Sharpe ratio
-0.72
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About EBR/NYXH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ebr/NYXH stock rating?

ebr/NYXH is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ebr/NYXH analysis?

The full report lives at /stocks/ebr/NYXH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ebr/NYXH?

The latest report frames ebr/NYXH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ebr/NYXH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.